HIIFS
ALXN

Harel Insurance Investments & Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-197
Closed -$118K – 841
2021
Q2 		$118K Buy
+197
New +$33.8K ﹤0.01% 622
2019
Q1 		– Sell
-4,500
Closed -$438K – 530
2018
Q4 		$438K Buy
+4,500
New +$532K 0.03% 113
2018
Q3 		– Sell
-2,200
Closed -$273K – 527
2018
Q2 		$273K Sell
2,200
-1,000
-31% -$117K 0.01% 168
2018
Q1 		$357K Buy
+3,200
New +$382K 0.02% 164
2016
Q3 		– Sell
-69
Closed -$8K – 689
2016
Q2 		$8K Buy
+69
New +$9.79K ﹤0.01% 582

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ALXN Position: Q3 2021 in Review

Harel Insurance Investments & Financial Services sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 197 shares — an estimated $118K sold.

Harel Insurance Investments & Financial Services first reported a position in ALXN in Q2 2016 and held it in 5 quarters. The position peaked at $438K in Q4 2018. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 197 Alexion Pharmaceuticals shares in Q3 2021, an estimated $118K.
  • Harel Insurance Investments & Financial Services first reported a position in Alexion Pharmaceuticals in Q2 2016 and held it in 5 quarters.
  • Harel Insurance Investments & Financial Services's Alexion Pharmaceuticals position peaked at $438K in Q4 2018.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2021, filed 25 Oct 2021.